Valuation: Medico Intercontinental Limited

Market Cap 250M 2.62M 2.36M 2.18M 1.97M 3.68M 3.73M 26.03M 10.37M 131M 9.85M 9.64M 415M P/E 2025
7.01x
P/E 2026 -7.97x
Enterprise Value 862M 9.05M 8.12M 7.5M 6.8M 12.7M 12.85M 89.73M 35.74M 451M 33.95M 33.23M 1.43B EV / Sales 2025
0.52x
EV / Sales 2026 1.02x
Free-Float
38.75%
Yield 2025 *
-
Yield 2026 -
08-14 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-22 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-14 Medico Intercontinental Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-08-14 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-07-14 Medico Intercontinental Limited Approves the Appointment of Puneeta Sharma as Company Secretary and Compliance Officer, Effective from 14 July, 2025 CI
25-05-30 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025 CI
25-04-22 Medico Intercontinental Limited Announces Resignation of Puneeta Sharma as Company Secretary & Compliance Officer, Effective 22 April, 2025 CI
24-11-14 Medico Intercontinental Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-08-13 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-25 Medico Intercontinental Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
24-05-25 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
24-04-25 Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director CI
24-04-09 Medico Intercontinental Limited Proposes to Incorporate Joint Venture Partnership Firm CI
1 week+6.75%
Current month+2.21%
1 month+0.36%
3 months+1.01%
6 months+1.79%
Current year-37.50%
1 week 21
Extreme 21
25.6
1 month 21
Extreme 21
29
Current year 20.61
Extreme 20.61
42.9
1 year 20.61
Extreme 20.61
43
3 years 20.61
Extreme 20.61
122
5 years 20.61
Extreme 20.61
122
10 years 8
Extreme 8
132.1
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2019-08-11
Compliance Officer - 2019-05-31
Director TitleAgeSince
Chairman - 2019-04-07
Director/Board Member 53 2019-03-22
Director/Board Member - 2022-11-13
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+6.75%-26.12%-72.51% 2.62M
+0.50%+1.38%+57.09%+129.96% 1,148B
+0.86%+5.14%+45.00%+86.15% 652B
-0.14%+0.42%+25.69%+105.85% 505B
+0.55%+2.07%+53.69%+65.85% 384B
-0.63%-5.97%+61.93%+37.06% 348B
+2.03%+1.72%+33.10%+54.91% 294B
+1.19%-0.72%+2.60%+26.11% 264B
+0.87%+3.08%+54.69%+72.74% 244B
+0.08%+3.67%+35.05%+107.78% 197B
Average +0.52%+1.80%+34.27%+61.39% 403.72B
Weighted average by Cap. +0.54%+1.50%+44.77%+88.97%

Financials

2025 2026
Net sales 963M 10.11M 9.07M 8.39M 7.59M 14.19M 14.36M 100M 39.93M 504M 37.93M 37.13M 1.6B 846M 8.88M 7.97M 7.37M 6.67M 12.47M 12.62M 88.11M 35.09M 443M 33.34M 32.63M 1.41B
Net income 50.57M 531K 476K 440K 399K 745K 754K 5.27M 2.1M 26.46M 1.99M 1.95M 84.01M -32.01M -336K -302K -279K -252K -472K -477K -3.33M -1.33M -16.75M -1.26M -1.23M -53.17M
Net Debt 142M 1.49M 1.34M 1.24M 1.12M 2.1M 2.12M 14.82M 5.9M 74.48M 5.61M 5.49M 236M 612M 6.42M 5.76M 5.33M 4.82M 9.01M 9.12M 63.69M 25.37M 320M 24.1M 23.59M 1.02B
Projected Income Statement - Annual - Medico Intercontinental Limited
Logo Medico Intercontinental Limited
Medico Intercontinental Ltd is engaged in the business of trading pharmaceutical products. It provides a platform for all research-based biopharmaceutical companies. Its product categories include Gastro, Uro, Nutrition, Cosmetology, Health devices, Hospital, and other areas. Its products include ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, ALFACARE-D3, ARSUFACT Combokit, BALOFACT, CYCLOFACT 400, UDIFACT 150, XOFACT-4, ZIFT SL-250, ZYMIX, ARGIFACT, CLIANCIACT POWDER, RELIEVE CZ, VOLIREX SPRAY, RACIMAX SACHET, PERMACT, OROFACT, KTZ, FEMYACT, LIVOFACT, ZYMIX SY, ULTRATONE SY, ALBECTIN SUS, BECOFACT DROPS, MEFACT P SUS, ONCARE SOLUTION, OFCARE-FORTE SUS, PRODOM CV SY, RELIBEN SUSP, ZIFT SUSP-200, MGCIPACT EYE DROP, OROFACT-PASTE (lamy), OROFACT MOUTH ULCER GEL, CAMBOGIA, LUBRIACT, HIZEN, and CALAMED LOTION. Its subsidiaries include Evagrace Pharma Private Limited, Ritz Formulations Private Limited, Sungrace Pharma Private Limited, and Azillian Healthcare Private Limited.
Employees
41
Date Price Change Volume
26-10-29 ₹25.00 0.00% 68
26-10-28 ₹25.00 +1.67% 666
26-10-27 ₹24.59 +2.46% 1,427
26-10-26 ₹24.00 +6.19% 1,057
26-10-23 ₹22.60 -3.50% 390
  1. Stock Market
  2. Stocks
  3. ICLF Stock